Blackstone has started interviewing investment banks keen to help it secure a $1 billion payday at clinical trials business Nucleus Networks, Street Talk can reveal. The buyout firm on Thursday was ...

Deal enhances existing value, evidence, and market access solutions as demand for economic and outcomes services accelerates Red Nucleus, a leading provider of strategic services across research and ...

Red Nucleus is doubling down on health economics and outcomes research (HEOR) as payer scrutiny, pricing pressure and evidence demands reshape how therapies reach — and stay on — the market. The ...

Tony Dokoupil is the anchor of the new "CBS Evening News with Tony Dokoupil." He previously served as co-host of "CBS Mornings" and anchored "The Uplift," a weekly series spotlighting positive and ...

Just as life pulsates in big vibrant cities, it also prospers in crowded environments inside cells. The interior of cells is densely packed with biomolecules like proteins and nucleic acids. How is ...

LONDON, Sept 15 (Reuters) - HPS Investment Partners is weighing a sale of British financial advice platform Nucleus Financial Platforms, four people familiar with the matter told Reuters. Sign up here ...

SALT LAKE CITY — The Beehive State is continuing to push the envelope when it comes to innovation with a Wednesday unveiling of a first-of-its-kind Nucleus Institute. The initiative aims to bring ...

ROCHESTER — Nucleus RadioPharma, the downtown Rochester-based, Mayo Clinic-co-founded radioactive drug maker, has a new chief executive officer. Dr. Stephen Hahn is a physician, former chief medical ...

Nucleus RadioPharma, a CDMO that specializes in the burgeoning field of radiopharmaceuticals, named former FDA Commissioner Dr. Stephen Hahn as its chief executive officer. Hahn, who led the federal ...

Hahn brings a rare combination of regulatory experience, clinical expertise and operational leadership to unlock the full potential of radiopharmaceuticals. ROCHESTER, Minn.--(BUSINESS WIRE)--Nucleus ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Cancer treatment company Nucleus ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.